- Home
- KIND vs ORGO Comparison
KIND vs ORGO Comparison
Compare KIND & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIND
- ORGO
- Stock Information
- Founded
- KIND 2011
- ORGO 1985
- Country
- KIND United States
- ORGO United States
- Employees
- KIND N/A
- ORGO N/A
- Industry
- KIND Computer Software: Programming Data Processing
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- KIND Technology
- ORGO Health Care
- Exchange
- KIND Nasdaq
- ORGO Nasdaq
- Market Cap
- KIND 544.2M
- ORGO 533.9M
- IPO Year
- KIND N/A
- ORGO N/A
- Fundamental
- Price
- KIND $1.37
- ORGO $3.06
- Analyst Decision
- KIND Buy
- ORGO Buy
- Analyst Count
- KIND 3
- ORGO 2
- Target Price
- KIND $2.75
- ORGO $5.50
- AVG Volume (30 Days)
- KIND 1.9M
- ORGO 2.2M
- Earning Date
- KIND 05-07-2025
- ORGO 05-08-2025
- Dividend Yield
- KIND N/A
- ORGO N/A
- EPS Growth
- KIND N/A
- ORGO N/A
- EPS
- KIND N/A
- ORGO N/A
- Revenue
- KIND $248,306,000.00
- ORGO $458,760,000.00
- Revenue This Year
- KIND $5.45
- ORGO $3.31
- Revenue Next Year
- KIND $11.79
- ORGO $12.50
- P/E Ratio
- KIND N/A
- ORGO N/A
- Revenue Growth
- KIND 12.01
- ORGO 5.35
- 52 Week Low
- KIND $1.35
- ORGO $2.17
- 52 Week High
- KIND $3.00
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- KIND 33.51
- ORGO 29.39
- Support Level
- KIND $1.35
- ORGO $5.14
- Resistance Level
- KIND $1.57
- ORGO $5.55
- Average True Range (ATR)
- KIND 0.08
- ORGO 0.39
- MACD
- KIND 0.01
- ORGO -0.06
- Stochastic Oscillator
- KIND 6.82
- ORGO 6.04
About KIND Nextdoor Holdings Inc.
Nextdoor Holdings Inc is the platform to connect to the neighborhoods. The purpose is to cultivate a kinder world where everyone has a neighborhood. Neighbors around the world turn to Nextdoor daily to receive trusted information, give and get help, get things done, and build real-world connections with nearby neighbors, businesses, and public services. It offers a comprehensive suite of advertising solutions designed to deliver exceptional value for businesses of all size.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.